TGFB1 and cancer: Primarily, 565 samples in TCGA cohort were sorted into six subtypes according to pan-cancer immune phenotype set by a previous study (C1, wound healing; C2, IFN-γ dominant; C3, inflammatory; C4, lymphocyte depleted; C5, immunologically quiet; C6, TGF-β dominant) (31).